Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
- Conditions
- Heart Failure
- Interventions
- Drug: LMI 1195
- First Posted Date
- 2010-03-11
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Lantheus Medical Imaging
- Registration Number
- NCT01085175
- Locations
- 🇺🇸
Columbia University Medical College, New York, New York, United States
Study of [3H] BMS747158 in Healthy Male Subjects
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: [3H] BMS747158
- First Posted Date
- 2009-06-30
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 7
- Registration Number
- NCT00930631
- Locations
- 🇺🇸
Covance Clinical Laboratory Unit, Madison, Wisconsin, United States
A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 32
- Registration Number
- NCT00918866
- Locations
- 🇺🇸
Cardiovascular Consultants, Kansas City, Missouri, United States
🇺🇸The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
- Conditions
- Heart Failure
- Interventions
- Drug: LMI 1195-101
- First Posted Date
- 2009-05-01
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 12
- Registration Number
- NCT00891241
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
🇺🇸Yale University Medical Center, New Haven, Connecticut, United States
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
- Conditions
- Ischemia
- Interventions
- Drug: BMS747158
- First Posted Date
- 2009-02-23
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 176
- Registration Number
- NCT00849108
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸University Hospital Case Medical Center, Cleveland, Ohio, United States
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
- Conditions
- Healthy Volunteers
- Interventions
- Drug: BMS747158
- First Posted Date
- 2008-07-01
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 12
- Registration Number
- NCT00707538
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸John Hopkins University, Baltimore, Maryland, United States
A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158
- Conditions
- Healthy
- Interventions
- Drug: BMS747158
- First Posted Date
- 2008-07-01
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 13
- Registration Number
- NCT00707499
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 1060
- Registration Number
- NCT00625365
- Locations
- 🇺🇸
York Hospital, York, Pennsylvania, United States
🇺🇸University of Texas Medical Center, Galveston, Texas, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
- Conditions
- Ventricular Ejection Fraction
- First Posted Date
- 2006-11-20
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 131
- Registration Number
- NCT00401687
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸Saint Lukes Mid America Heart Institute, Kansas City, Missouri, United States
A Phase II Study of DMP 115 to Assess Focal Liver Lesions
- Conditions
- Liver Disease
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2011-08-18
- Lead Sponsor
- Lantheus Medical Imaging
- Target Recruit Count
- 80
- Registration Number
- NCT00162058
- Locations
- 🇬🇧
Local Institution, Glasgow, Scotland, United Kingdom